Secondary Hyperparathyroidism Animal Studies
Research from INSERM yields new findings on secondary hyperparathyroidism animal studies
Published in Gastroenterology Week, March 2nd, 2009
A new study, 'Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues,' is now available. "The recent introduction of calcimimetics, a novel class of therapeutic agents, has led to a change in the treatment strategy of secondary hyperparathyroidism in patients with end-stage renal disease. In initial acute studies in chronic hemodialysis patients, the calcimimetic cinacalcet was shown to reduce plasma intact parathyroid hormone within hours, followed by a rapid, profound decrease in plasma calcium and a minor decrease in plasma phosphorus," investigators in Paris, France report.
"Subsequent reports showed that the long-term...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- American College of Cardiology
Elderly patients can benefit from selective use of early revascularization - Burnham Institute
Stem cell research uncovers mechanism for type 2 diabetes - Henry Ford Health System
Arab-American women need supplement to boost dangerously low vitamin D levels - JAMA and Archives Journals
Genetic ID of marker in lymph nodes may be linked to colorectal cancer recurrence risk - Thomas Jefferson University
Biomarker predicts disease recurrence in colorectal cancer - University Hospital Heidelberg
Hope for preventative treatment for cystic fibrosis lung disease - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
